58 Development and characterization of novel orally available Hypoxiainducible factor (HIF) signaling inhibitors as dual-mechanism cancer therapeutics Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Schultes, C
  • Alonso, J
  • Encinas-Lopez, A
  • Leber, Brian
  • Mülbaier, M
  • Thermann, R
  • Thomson, D
  • Wawro, S
  • Janssen, B
  • Lewis, J

publication date

  • November 2010